These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 22680981

  • 1. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
    Nishijima T, Kawasaki Y, Tanaka N, Mizushima D, Aoki T, Watanabe K, Kinai E, Honda H, Yazaki H, Tanuma J, Tsukada K, Teruya K, Kikuchi Y, Gatanaga H, Oka S.
    AIDS; 2014 Aug 24; 28(13):1903-10. PubMed ID: 25259702
    [Abstract] [Full Text] [Related]

  • 6. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir.
    Young J, Wang Q, Fux CA, Bernasconi E, Furrer H, Vernazza P, Calmy A, Cavassini M, Weber R, Battegay M, Bucher HC, Swiss HIV Cohort Study.
    HIV Med; 2014 Sep 24; 15(8):505-10. PubMed ID: 24641488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM.
    Clin Infect Dis; 2007 Dec 15; 45(12):1633-9. PubMed ID: 18190326
    [Abstract] [Full Text] [Related]

  • 9. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.
    Mauss S, Berger F, Filmann N, Hueppe D, Henke J, Hegener P, Athmann C, Schmutz G, Herrmann E.
    J Hepatol; 2011 Dec 15; 55(6):1235-40. PubMed ID: 21703180
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
    Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P.
    Clin Infect Dis; 2011 Jul 01; 53(1):84-91. PubMed ID: 21653308
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased risk of dialysis and end-stage renal disease among HIV patients in Denmark compared with the background population.
    Rasch MG, Helleberg M, Feldt-Rasmussen B, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Gerstoft J, Obel N.
    Nephrol Dial Transplant; 2014 Jun 01; 29(6):1232-8. PubMed ID: 23975841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
    Calza L, Trapani F, Salvadori C, Magistrelli E, Manfredi R, Colangeli V, Di Bari MA, Borderi M, Viale P.
    Scand J Infect Dis; 2013 Feb 01; 45(2):147-54. PubMed ID: 22991923
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients.
    Tanaka H, Arai M, Tomoda Y, Wada T, Yago K, Satoh M.
    J Pharm Pharm Sci; 2013 Feb 01; 16(3):405-13. PubMed ID: 24021289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
    De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, Delaporte E, ANRS 1215 Study Group.
    AIDS Res Hum Retroviruses; 2010 Nov 01; 26(11):1221-7. PubMed ID: 20854202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.